Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
about
Intratympanic glucocorticoids for sudden sensorineural hearing lossAssessing the cause of tinnitus for therapeutic options.Microsystems technologies for drug delivery to the inner ear.Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.Localized cell and drug delivery for auditory prostheses.Drug delivery for treatment of inner ear disease: current state of knowledgeClinical practice guideline: sudden hearing loss.Primary observation of early transtympanic steroid injection in patients with delayed treatment of noise-induced hearing loss.Drug delivery to the ear.Issues, indications, and controversies regarding intratympanic steroid perfusionAre intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.Developments in delivery of medications for inner ear disease.The role of intracochlear drug delivery devices in the management of inner ear disease.Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality.Noninvasive intratympanic dexamethasone treatment for sudden sensorineural hearing loss.Intratympanic administration of methylprednisolone reduces impact of experimental intensive impulse noise trauma on hearing.Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.Novel drug delivery systems for inner ear protection and regeneration after hearing loss
P2860
Q24240942-4D0767FA-2D59-41EB-8368-41463AF46889Q30428296-F2BBF037-E696-45D1-8133-967BC027706BQ30447624-73500B0B-5FCF-4735-84CE-4DA60E1CCBFEQ30466045-B188FBBD-6A1C-44E0-8E70-0CD2168C68E2Q30475885-7FB1D32E-196C-460C-AB23-FB0E43B0E9CAQ30476020-06CB728C-248B-4D00-B8D6-43C12AD1A23CQ34258137-2FE847A2-1831-4F67-A8DF-AE41CFAE0F77Q34499124-94322D6A-B33F-4D21-925D-B604092B204DQ34549540-A240CB36-282D-49F5-BD37-C9B4EE19F49BQ37146991-2083C12A-9976-4152-8472-8113DF7729F3Q37919754-134B5C91-620E-446C-9D4B-BEC3DD026559Q38096427-1F2A481E-A249-4E82-8313-CAF78C055D66Q38262931-C6AA56AD-FE32-4579-9FFD-9BE48D1F08F0Q39010893-1B9A2313-AC15-4668-B7B3-BE3F42A2DC42Q39637189-BF0915F4-8236-4494-89A8-FAD404737873Q45305480-5E99D47F-FC2A-4B25-870E-4F1296F2E7EEQ46171484-DF3B255E-2430-4F66-906B-8161D75E4EC5Q50356944-F0AB5220-81E9-46A9-A600-0520562480E3Q58767632-2E6578EF-F872-4F66-A395-8E735C9D3A57
P2860
Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Topical steroid therapy using ...... ure of conventional treatment.
@en
Topical steroid therapy using ...... ure of conventional treatment.
@nl
type
label
Topical steroid therapy using ...... ure of conventional treatment.
@en
Topical steroid therapy using ...... ure of conventional treatment.
@nl
prefLabel
Topical steroid therapy using ...... ure of conventional treatment.
@en
Topical steroid therapy using ...... ure of conventional treatment.
@nl
P2860
P1476
Topical steroid therapy using ...... ure of conventional treatment.
@en
P2093
France Van Wijck
Philippe P Lefebvre
P2860
P304
P356
10.1080/00016480601126952
P407
P577
2007-10-01T00:00:00Z